These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3115267)

  • 21. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
    Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential aldose reductase inhibitors: 1,2,4-triazolidine-3,5-diones and 2-(3,4,5-trimethoxybenzoyl)-4,4-diethyl-3,5-isoxazolidinedione .
    Hall IH; Izydore RA; Simlot R; Wong OT
    Experientia; 1992 Apr; 48(4):383-6. PubMed ID: 1582496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR; Sidenius P; Larsen JR
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues.
    Jung SH; Lee YS; Lee S; Lim SS; Kim YS; Shin KH
    Arch Pharm Res; 2002 Jun; 25(3):306-12. PubMed ID: 12135102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotationally restricted mimics of rigid molecules: nonspirocyclic hydantoin aldose reductase inhibitors.
    Rizzi JP; Schnur RC; Hutson NJ; Kraus KG; Kelbaugh PR
    J Med Chem; 1989 Jun; 32(6):1208-13. PubMed ID: 2498517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix.
    Aida K; Tawata M; Shindo H; Onaya T; Sasaki H; Yamaguchi T; Chin M; Mitsuhashi H
    Planta Med; 1990 Jun; 56(3):254-8. PubMed ID: 2118267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.
    Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB
    Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat.
    Kemper C; Dvornik D
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of peripheral nerve dysfunction by an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Kikkawa R; Hatanaka I; Yasuda H; Kobayashi N; Shigeta Y
    Metabolism; 1984 Mar; 33(3):212-4. PubMed ID: 6420645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of aldose reductase in five tissues of the streptozotocin-diabetic rat.
    Poulsom R; Heath H
    Biochem Pharmacol; 1983 May; 32(9):1495-9. PubMed ID: 6407486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF; Akagi Y; Kinoshita JH
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract]   [Full Text] [Related]  

  • 36. The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses.
    Williams WF; Odom JD
    Exp Eye Res; 1987 Jun; 44(6):717-30. PubMed ID: 3115803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Na+-K+-ATPase pumping activity is not directly linked to myo-inositol levels after sorbinil treatment in lenses of diabetic rats.
    Yeh LA; Rafford CE; Goddu KJ; Ashton MA; Beyer TA; Hutson NJ
    Diabetes; 1987 Dec; 36(12):1414-9. PubMed ID: 2824260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors.
    Sredy J; Flam BR; Sawicki DR
    Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.